Literature DB >> 6780605

Methodological variation in antibiotic synergy tests against enterococci.

R W Ryan, I Kwasnik, R C Tilton.   

Abstract

Thirty-two human isolates of enterococci were tested for antibiotic synergy by using penicillin and one of six aminoglycosides. Three methods were used: synergy screen, microdilution checkerboard, and time-kill curves. The synergy screen accurately predicted synergy for gentamicin-penicillin combinations, and this synergy was later confirmed by time-kill curves. The microdilution checkerboard method suffered from inherent variation, and agreement with time-kill curves ranged from 92% (twofold reduction in minimum inhibitory concentration) to 4.2% (fourfold reduction in minimum inhibitory concentration). We suggest that enterococci be screened for synergy (i.e., presence or absence of high-level resistance) by using the criterion of growth or no growth in the presence of 2,000 microgram of an aminoglycoside per ml. The microdilution checkerboard test for synergy is not recommended.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6780605      PMCID: PMC273724          DOI: 10.1128/jcm.13.1.73-75.1981

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  8 in total

1.  Resistance to six aminoglycosidic aminocyclitol antibiotics among enterococci: prevalence, evolution, and relationship to synergism with penicillin.

Authors:  S A Calderwood; C Wennersten; R C Moellering; L J Kunz; D J Krogstad
Journal:  Antimicrob Agents Chemother       Date:  1977-09       Impact factor: 5.191

2.  Comparison of techniques for measurement of in vitro antibiotic synergism.

Authors:  C W Norden; H Wentzel; E Keleti
Journal:  J Infect Dis       Date:  1979-10       Impact factor: 5.226

3.  Comparative efficacy and toxicity of amikacin/carbenicillin versus gentamicin/carbenicillin in leukopenic patients: a randomized prospective trail.

Authors:  W K Lau; L S Young; R E Black; D J Winston; S R Linne; R J Weinstein; W L Hewitt
Journal:  Am J Med       Date:  1977-06       Impact factor: 4.965

4.  Synergism of cefazolin-gentamicin against enterococci.

Authors:  M Bourque; R Quintiliani; R C Tilton
Journal:  Antimicrob Agents Chemother       Date:  1976-07       Impact factor: 5.191

5.  Studies on antibiotic synergism against enterococci. I. Bacteriologic studies.

Authors:  R C Moellering; C Wennersten; A N Weinberg
Journal:  J Lab Clin Med       Date:  1971-05

6.  Significance of antimicrobial synergism for the outcome of gram negative sepsis.

Authors:  J Klastersky; F Meunier-Carpentier; J M Prevost
Journal:  Am J Med Sci       Date:  1977 Mar-Apr       Impact factor: 2.378

7.  Comparison of methods for assessing in vitro antibiotic synergism against Pseudomonas and Serratia.

Authors:  R J Weinstein; L S Young; W L Hewitt
Journal:  J Lab Clin Med       Date:  1975-11

8.  Penicillin-tobramycin synergism against enterococci: a comparison with penicillin and gentamicin.

Authors:  R C Moellering; C Wennersten; A J Weinstein
Journal:  Antimicrob Agents Chemother       Date:  1973-04       Impact factor: 5.191

  8 in total
  9 in total

Review 1.  Screening and treatment of infections caused by resistant enterococci.

Authors:  D J Herman; D N Gerding
Journal:  Antimicrob Agents Chemother       Date:  1991-02       Impact factor: 5.191

2.  Activity of LY146032 in vitro and in experimental enterococcal pyelonephritis.

Authors:  P M Miniter; T F Patterson; M A Johnson; V T Andriole
Journal:  Antimicrob Agents Chemother       Date:  1987-08       Impact factor: 5.191

3.  Comparison of three different in vitro methods of detecting synergy: time-kill, checkerboard, and E test.

Authors:  R L White; D S Burgess; M Manduru; J A Bosso
Journal:  Antimicrob Agents Chemother       Date:  1996-08       Impact factor: 5.191

Review 4.  Antibiotic combinations: should they be tested?

Authors:  G M Eliopoulos; C T Eliopoulos
Journal:  Clin Microbiol Rev       Date:  1988-04       Impact factor: 26.132

5.  Synergism between aminoglycosides and cephalosporins with antipseudomonal activity: interaction index and killing curve method.

Authors:  H O Hallander; K Dornbusch; L Gezelius; K Jacobson; I Karlsson
Journal:  Antimicrob Agents Chemother       Date:  1982-11       Impact factor: 5.191

6.  Fractional maximal effect method for in vitro synergy between amoxicillin and ceftriaxone and between vancomycin and ceftriaxone against Enterococcus faecalis and penicillin-resistant Streptococcus pneumoniae.

Authors:  N Desbiolles; L Piroth; C Lequeu; C Neuwirth; H Portier; P Chavanet
Journal:  Antimicrob Agents Chemother       Date:  2001-12       Impact factor: 5.191

7.  Pharmacodynamic Interaction of Quercus infectoria Galls Extract in Combination with Vancomycin against MRSA Using Microdilution Checkerboard and Time-Kill Assay.

Authors:  Dayang Fredalina Basri; Radhiah Khairon
Journal:  Evid Based Complement Alternat Med       Date:  2012-07-31       Impact factor: 2.629

8.  Interaction Tolerance Detection Test for Understanding the Killing Efficacy of Directional Antibiotic Combinations.

Authors:  Jia-Feng Liu; Orit Gefen; Zi-Yin Zhang; Min-Min Liu; Maskit Bar-Meir; Nathalie Q Balaban
Journal:  mBio       Date:  2022-02-15       Impact factor: 7.786

Review 9.  When One Drug Is Not Enough: Context, Methodology, and Future Prospects in Antibacterial Synergy Testing.

Authors:  Thea Brennan-Krohn; James E Kirby
Journal:  Clin Lab Med       Date:  2019-06-12       Impact factor: 1.935

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.